Could your own lung cells heal COPD? a new stem cell trial aims to find out
NCT ID NCT06946953
First seen Jul 20, 2026 · Last updated Jul 22, 2026 · Updated 2 times
Summary
This study tests an experimental therapy called REGEND001 for people with moderate to severe COPD. The treatment uses a patient's own lung stem cells, collected via a bronchial brush, grown in a lab, and then infused back into the lungs. The goal is to see if it can safely improve the lungs' ability to transfer oxygen and ease symptoms. The trial involves 20 participants and follows them for 24 weeks after treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a stem cell therapy made from the patient's own lung cells, called REGEND001
- What this could lead to
- If successful, this could lead to a treatment that repairs lung damage in COPD patients, potentially improving breathing and quality of life beyond current symptom management.
- What could go wrong
- This is an early-phase trial with only 20 participants, so results may not apply to all COPD patients. The therapy involves invasive procedures and there is a risk of side effects or no benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ruijin Hospital Hainan Branch, Shanghai Jiao Tong University School of Medicine
RECRUITINGQionghai, Hainan, 571437, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine
RECRUITINGShanghai, Shanghai Municipality, 200025, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A smarter way to track lung disease? new platform aims to personalize COPD and IPF care
- Breathing easy: dynamic x-rays may spot COPD faster and safer
- Common mucus-thinning drugs may improve outcomes in COPD patients with lung cancer
- Could a simple screening strategy uncover hidden TB in COPD patients?
- Routine blood test may reveal hidden clues in COPD emergencies
- Personalized lung decline forecast aims to boost smoking cessation in COPD